BCL2 and cerebral infarction: Bcl‐2 overexpression of transgenic mice significantly reduced the volume of cerebral infarction after focal ischemia, whereas Bcl‐2 knockout mice showed the increase in infarct volume (Hata, Gillardon, Michaelidis, & Hossmann, 1999; Martinou et al., 1994).